JIXING PHARMACEUTICALS
Jixing Pharmaceuticals develops innovative science and medicines to underserved Chinese patients with serious and life-threatening diseases.
JIXING PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.jixingbio.com
Total Employee:
11+
Status:
Active
Contact:
+86-021-80311808
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Investors List
RTW Investments LLC
RTW Investments LLC investment in Series B - Jixing Pharmaceuticals
Official Site Inspections
http://www.jixingbio.com
- Host name: 40.73.39.95
- IP address: 40.73.39.95
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Jixing Pharmaceuticals"
Jixing Pharmaceuticals - Crunchbase Company Profile …
Jixing Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.See details»
CORXEL • Our companies • RTW Investments
Formed by RTW in early 2019, CORXEL is a leading biotechnology company committed to bringing innovative science and medicines to underserved patients in China.See details»
Ji Xing Pharmaceuticals Limited (JIXING) - life-sciences-asia.com
JIXING is a biopharmaceutical company headquartered in Shanghai committed to bringing innovative science and medicines to underserved patients in China with serious and life …See details»
JIXING ANNOUNCES THE APPOINTMENT OF KUN WU AS THE …
Mar 31, 2022 Kun brings strong biopharmaceutical expertise and will be responsible to build JIXING’s commercial strategy & organization SHANGHAI, China, March 31, 2022 – Ji Xing …See details»
JIXING - 2025 Company Profile, Funding & Competitors - Tracxn
May 13, 2025 JIXING - Developer of therapeutics for cardiovascular and ophthalmic conditions. Raised a total funding of $127M over 1 round from 2 investors.See details»
JIXING Announces Leadership Transition – Press releases – CORXEL ...
Jun 17, 2025 SHANGHAI, China, April 20, 2022 – Ji Xing Pharmaceuticals Limited (“JIXING”), a clinical-stage biopharmaceutical company committed to bringing innovative medicines to …See details»
Ji Xing Pharmaceuticals - Overview, News & Similar companies
Feb 11, 2024 View Ji Xing Pharmaceuticals (www.jixingbio.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. - cnverify.com
Country: China Legal Representative: Mou Yanping Business status: Active Industry: Other technical promotion services Company type: Limited Liability Company (Solely Proprieted by …See details»
Jixing Pharmaceuticals Information - RocketReach
Jixing Pharmaceuticals is a Pharmaceutical Manufacturing company_reader located in CN with 36 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Bayer and RTW Investments lead Series D financing in Chinese …
Berlin, Germany, New York City, USA and Shanghai, China, January 6, 2024 – Bayer and RTW Investments, LP (“RTW”) today announced an equity investment into Ji Xing Pharmaceuticals …See details»
Hovione and JIXING Announce an Exclusive Global License …
May 9, 2022 For further information about JIXING, please visit www.jixingbio.com About Hovione: Hovione is an international company with over 60 years of experience as a Contract …See details»
JIXING Announces the Grand Opening of the New Headquarter
Sep 7, 2022 A new start for a bright future SHANGHAI, China, September 7, 2022 – Ji Xing Pharmaceuticals Limited (JIXING), a clinical-stage biopharmaceutical company committed to …See details»
JIXINGAnnouncestheNewHeadquarterOfficeOpeninginChina
Sep 7, 2022 For additional information about JIXING, visit www.jixingbio.com . Media Contact Ji Xing Pharmaceuticals [email protected] Click the button below and follow our official …See details»
JiXing: Disruptive science, driven by heart - RTW Investments
Sep 26, 2022 The need We formed JiXing in early 2020, borne out of a two-year study of innovation, biotechnology, and access to healthcare in China. JIXING is a leading …See details»
LENZ Therapeutics and JIXING Announce an Exclusive Greater …
Apr 13, 2022 For further information about JIXING, please visit www.jixingbio.com. About RTW RTW Investments, LP (RTW) is a New York-based, global, full life-cycle investment firm that …See details»
JIXING Announces the Grand Opening of the New Headquarter …
Jun 21, 2025 A new start for a bright future SHANGHAI, China, September 7, 2022 – Ji Xing Pharmaceuticals Limited (JIXING), a clinical-stage biopharmaceutical company committed to …See details»
Hovione and JIXING Announce an Exclusive Global License …
Lisbon, Portugal and Shanghai, China, 9 May 2022 – Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical …See details»
JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY …
Feb 16, 2022 Media Contact Ji Xing Pharmaceuticals [email protected] References: 1. Heart failure committee of Chinese medical association, Editorial board of the Chinese journal …See details»
JIXINGAcquiredACardiovascularAssetForGlobalDevelopment
Feb 6, 2023 For additional information about JIXING, visit www.jixing.com. Media Contact Ji Xing Pharmaceuticals [email protected] References ·Lee J, Schotzinger J, et al. The …See details»
JIXING Acquires BIIB131 from Biogen to Treat Acute Ischemic Stroke
Jun 21, 2025 Jixing Pharmaceuticals will develop investigational drug globally Shanghai, China– January 11, 2024 –Ji Xing Pharmaceuticals (“JIXING”), a clinical-stage biopharmaceutical …See details»